Boston-founded ovarian cancer biotech is officially a Colorado company


Denver is now home to AOA Dx, a biotech startup developing an early ovarian cancer detection tool. The startup was founded in 2020 in Boston, but after raising a $17 million round in October it announced its next stage of growth would take place in Colorado.

Read More